Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 13
2008 12
2009 4
2010 13
2011 15
2012 14
2013 20
2014 17
2015 12
2016 13
2017 12
2018 10
2019 5
2020 5
2021 12
2022 5
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Erythropoietin Stimulating Agents.
Schoener B, Borger J. Schoener B, et al. 2023 Mar 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2023 Mar 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30725682 Free Books & Documents.
Examples of ESAs are epoetin, darbepoetin, and methoxy polyethylene glycol-epoetin beta. ...This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of ESAs in …
Examples of ESAs are epoetin, darbepoetin, and methoxy polyethylene glycol-epoetin beta. ...This a …
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Cochrane Database Syst Rev. 2014. PMID: 25486075 Free PMC article. Updated. Review.
SELECTION CRITERIA: Randomised controlled trials (RCTs) that included a comparison of an ESA (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, or biosimilar ESA) with another ESA, place …
SELECTION CRITERIA: Randomised controlled trials (RCTs) that included a comparison of an ESA (epoetin alfa, epoetin beta …
Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.
Curran MP, McCormack PL. Curran MP, et al. Drugs. 2008;68(8):1139-56. doi: 10.2165/00003495-200868080-00009. Drugs. 2008. PMID: 18484803 Review.
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin receptor activator, with a long half-life (approximately 130 hours). ...Methoxy polyethylene glycol-epoetin …
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin recept …
Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.
Schmid H. Schmid H. Expert Rev Hematol. 2016 Jan;9(1):5-20. doi: 10.1586/17474086.2016.1112734. Epub 2015 Nov 17. Expert Rev Hematol. 2016. PMID: 26573694 Review.
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney disease. Methoxy polyethylene glycol-epoetin beta (MPG-EPO), also called continuous erythropoietin …
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney dis …
The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease.
Abood SJ, Abdulsahib WK, Al-Radeef MY. Abood SJ, et al. Heliyon. 2023 Feb 14;9(2):e13747. doi: 10.1016/j.heliyon.2023.e13747. eCollection 2023 Feb. Heliyon. 2023. PMID: 36865462 Free PMC article.
AIM: This research aimed to investigate the relation between resistance to the methoxy polyethylene glycol-epoetin beta (ME-beta) and angiotensin-converting enzyme (ACE) gene polymorphism. ...Comparing ACE polymorphism between good and hy …
AIM: This research aimed to investigate the relation between resistance to the methoxy polyethylene glycol-epoetin …
Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.
Piotr B, Mariusz S, Jacek R. Piotr B, et al. Curr Pharm Biotechnol. 2017;18(4):303-308. doi: 10.2174/1389201018666170127104801. Curr Pharm Biotechnol. 2017. PMID: 28137221 Review.
Literature data indicate the usefulness of long-acting ESAs in treatment of anemia in non-dialysis CKD patients. In particular, continuous erythropoietin receptor activator seems to be a good choice in these patients because of its efficiency, safety a …
Literature data indicate the usefulness of long-acting ESAs in treatment of anemia in non-dialysis CKD patients. In particular, continuou …
Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients.
Choy BY, Lam MF, Yip T, Tang HL, Wong PN, Chow CC, Yap DY, Chan TM. Choy BY, et al. Nephrology (Carlton). 2013 Aug;18(8):533-8. doi: 10.1111/nep.12105. Nephrology (Carlton). 2013. PMID: 23714233
AIM: To investigate methoxy polyethylene glycol-epoetin beta dosing regimen in treatment naive subjects and dose conversion in darbepoetin alpha treated subjects, in Chinese dialysis patients. ...In Group I methoxy polyethylene …
AIM: To investigate methoxy polyethylene glycol-epoetin beta dosing regimen in treatment naive subjects a …
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.
Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB. Locatelli F, et al. Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1701-1710. doi: 10.2215/CJN.01380219. Epub 2019 Aug 16. Clin J Am Soc Nephrol. 2019. PMID: 31420350 Free PMC article. Clinical Trial.
We compared cardiovascular outcomes and all-cause mortality associated with monthly methoxy polyethylene glycol-epoetin beta with those of the shorter-acting agents epoetin alfa/beta and darbepoetin alfa in patients with anemia of …
We compared cardiovascular outcomes and all-cause mortality associated with monthly methoxy polyethylene glycol-epoe …
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. Chung EY, et al. Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3. Cochrane Database Syst Rev. 2023. PMID: 36791280 Review.
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, and biosimilar E …
This is an update of a Cochrane review first published in 2014. OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, …
164 results